Archive for July, 2008

Canadian ISPs Plan Net Censorship

Mike Finch
American Free Press
July 12, 2008

A net-neutrality activist group has uncovered plans for the demise of the free Internet by 2010 in Canada. By 2012, the group says, the trend will be global.

Bell Canada and TELUS, Canada’s two largest Internet service providers (ISPs), will begin charging per-site fees on most Internet sites, reports anonymous sources within TELUS.

It’s beyond censorship, it is killing the biggest ecosystem of free expression and freedom of speech that has ever existed,” I Power spokesperson Reese Leysen said. I Power was the first group to report on the possible changes.

Bell Canada has not returned calls or emails. Read the rest of this entry »

Tags: , , , , , , , , , , ,

Pharm Giant Kills 12 Argentine Babies in Vaccine Trials

By, Trading Markets on Thursday, July 10, 2008; Posted: 05:23 PM

Buenos Aires, Jul 10, 2008

At least 12 babies who were part of a clinical study to test the effectiveness of a vaccine against pneumonia have died over the past year in Argentina, the local press reported Thursday.

The study was sponsored by global drug giant GlaxoSmithKline and uses children from poor families, who are “pressured and forced into signing consent forms,” the Argentine Federation of Health Professionals, or Fesprosa, said.

“This occurs without any type of state control” and “does not comply with minimum ethical requirements,” Fesprosa said.

The vaccine trial is still ongoing despite the denunciations, and those in charge of the study were cited by the Critica newspaper as saying that the procedures are being carried out in a lawful manner. Read the rest of this entry »

Tags: , , , , , , , , , , , , , , , ,

Dr. Mercola talks about Sunscreen and Bug Spray

By, Dr. Mercola, July 2008

 

[youtube=http://www.youtube.com/watch?v=ZagY8DKvqzo]

You may be one of those people for whom summer is way too short!

But like it or not, you only have a few short months to enjoy the great outdoors in most of the continental US. Why waste it dealing with the two most vexing hassles of the outdoor summer season?

After spending six or more months stuck inside buildings under cover from rain, snow and sleet, you rush out and spend all day on a Saturday or Sunday in the sun. Not only is the golf course beckoning, but so is yard work, the kids’ sporting events, and the grill.

It’s easy to overdo your sun exposure in your quest to finally spend some time outdoors… especially when your skin is lily-white from being inside for months — and not used to the sun.

Did you consider sunscreen?

If you did, please recognize that it’s not exactly a foolproof solution. Keep reading to discover how your sunscreen can present its own set of health issues.

Visit Dr. Mercola’s site for the full article.

CDC Reports on Adverse Reactions to Gardasil Vaccine

By CBC News July 7, 2008 | 3:09 PM ET

Almost 8,000 U.S. recipients of the vaccine used to protect against cervical cancer have reported adverse reactions, ranging from pain at the injection site to serious side-effects, says the U.S. Centers for Disease Control and Prevention.

A total of 7,802 people who received Gardasil, made by Merck and Co. Inc., have reported adverse events to the CDC’s Vaccine Adverse Event Reporting System (VAERS) between June 8, 2006, and April 30, 2008. The United States distributed 2.2 million doses of the vaccine in 2006 and 11.3 million in 2007.

Of the people who reported adverse reactions, the most common side-effect was pain at the injection site, according to a recent CDC report.

Seven per cent had serious side-effects – “about half” the average of vaccines overall, according to the report. There were 31 reported cases of Guillain-Barré syndrome (GBS), a neurological condition that results in temporary but often total body paralysis, with 10 cases confirmed. Read the rest of this entry »

Tags: , , , , , , , , , , , , , , , , , , , , ,

GSK Faces US Delay on Cancer Vaccine

By Andrew Jack in London, FT.com July 1 2008 03:00

GlaxoSmithKline, the UK-based pharmaceutical company, is unlikely to receive US approval for its key cervical cancer vaccine until 2010 at the earliest, under a new timetable it released yesterday.

After requests for fresh information on Cervarix from the Food & Drug Administration in December, GSK said it had decided to await completion of a pivotal clinical trial to be filed with the US regulator during the first half of next year.

Cervarix is a probable blockbuster treatment that is central to the company’s future growth. The cervical cancer vaccine market is expected to be worth more than $1bn a year in sales.

GSK’s timetable change confirms long-standing analysts’ fears of delays for Cervarix, which is competing with a rival vaccine, Gardasil, produced by Merck of the US and already on sale in north America.

GSK filed originally for US approval from the FDA in March 2007, and it has refused to reveal the regulator’s precise concerns other than to say they relate to “safety and efficacy”.

Observers believe the queries focus on the nature of Cervarix’s proprietary adjuvant, a chemical that boosts the immune response to the vaccine. The FDA has not approved a new adjuvant since the 1930s. Read the rest of this entry »

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,